ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

29,142Medicare Part D Prescriptions Filled, Including Refills

Rank: 11 out of 939

$1.38M Total Retail Price of All Prescriptions

Rank: 16 out of 939

841 Patients Receiving at Least One Drug in Part D
73%Patients 65 Years and Older
73% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Arkansas
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 841 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

34% of this provider’s 841 patients filled at least one prescription for a schedule three drug, compared to an average of 19%.

Risky Drugs to Seniors

2% of this provider’s 20,490 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$47 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

35 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Arkansas
HYDROCODONE-ACETAMINOPHEN 1,773 1,035 S3 1 1
FUROSEMIDE 1,142 869 2 7
POTASSIUM CHLORIDE 1,098 848 3 9
AMLODIPINE BESYLATE 1,097 840 4 6
SIMVASTATIN 913 657 5 2
LEVOTHYROXINE SODIUM 738 579 6 4
METOPROLOL TARTRATE 624 499 7 10
HYDROCHLOROTHIAZIDE 607 442 8 12
ENALAPRIL MALEATE 553 338 9 65
PRAVASTATIN SODIUM 543 424 10 13
OMEPRAZOLE 505 383 11 5
WARFARIN SODIUM 452 354 12 17
MELOXICAM 431 365 13 14
NEXIUM 415 245 14 18
LISINOPRIL 398 300 15 3
ALLOPURINOL 352 274 16 31
DONEPEZIL HCL 346 346 17 30
METOPROLOL SUCCINATE 327 233 18 21
METFORMIN HCL 305 151 19 8
CLOPIDOGREL 292 240 20 28
ISOSORBIDE MONONITRATE ER 268 236 21 53
TAMSULOSIN HCL 253 215 22 27
GABAPENTIN 242 152 23 11
DIOVAN 235 199 24 50
IBUPROFEN 228 136 25 112
NAMENDA 222 214 26 49
LOSARTAN POTASSIUM 219 143 27 29
ALENDRONATE SODIUM 211 204 28 40
PLAVIX 208 169 29 48
SULFAMETHOXAZOLE-TRIMETHOPRIM 206 115 30 64
DIGOXIN 200 192 31 45
LANTUS 194 131 32 59
TRIAMTERENE-HCTZ 188 143 33 33
ATENOLOL 188 149 33 19
NIFEDIPINE ER 186 174 35 105
CARISOPRODOL 179 12 R 36 51
PROMETHAZINE HCL 163 95 R 37 68
ESCITALOPRAM OXALATE 163 104 37 61
LEVOFLOXACIN 162 106 39 86
METFORMIN HCL ER 161 97 40 76
PAROXETINE HCL 161 97 40 70
GLIPIZIDE XL 160 122 42 147
RISPERIDONE 159 101 43 82
LATANOPROST 157 135 44 233
CARVEDILOL 153 102 45 25
ATORVASTATIN CALCIUM 148 128 46 22
ZOLPIDEM TARTRATE 148 85 46 20
AZITHROMYCIN 145 89 48 32
CITALOPRAM HBR 144 103 49 15
POLYETHYLENE GLYCOL 3350 139 107 50 57
CYMBALTA 134 85 51 44
AMLODIPINE BESYLATE-BENAZEPRIL 132 101 52 58
CRESTOR 129 72 53 34
CYCLOBENZAPRINE HCL 126 54 R 54 36
CLONIDINE HCL 123 57 55 39
AMITRIPTYLINE HCL 119 59 R 56 38
DILTIAZEM ER 118 107 57 94
INSULIN SYRINGE 113 61 58 97
BENAZEPRIL HCL 110 102 59 87
VERAPAMIL ER 110 79 59 85
QUINAPRIL HCL 108 73 61 133
TERAZOSIN HCL 108 96 61 114
TRAMADOL HCL 107 62 63 16
PHENYTOIN SODIUM EXTENDED 107 91 63 99
LOSARTAN-HYDROCHLOROTHIAZIDE 104 89 65 55
DETROL LA 103 96 66 155
ADVAIR DISKUS 101 66 67 60
GEMFIBROZIL 97 56 68 100
DIOVAN HCT 96 83 69 74
SYNTHROID 95 88 70 75
NOVOLOG 94 76 71 145
PROAIR HFA 92 48 72 41
RANITIDINE HCL 90 64 73 35
PREMARIN 88 55 R 74 111
PROPRANOLOL HCL 87 70 75 117
ZETIA 86 49 76 103
AMIODARONE HCL 84 75 77 160
VENTOLIN HFA 83 44 78 80
LYRICA 83 14 78 63
SINGULAIR 80 37 80 101
NOVOLIN 70-30 80 71 80 211
MECLIZINE HCL 79 58 82 134
FLUOXETINE HCL 75 53 83 47
PHENYTOIN 74 47 84 288
NOVOLOG MIX 70-30 74 53 84 276
SERTRALINE HCL 74 58 84 24
RAMIPRIL 72 34 87 91
ENABLEX 72 31 87 303
CIPROFLOXACIN HCL 71 53 89 54
PREDNISONE 71 59 89 42
TRIAMTERENE-HYDROCHLOROTHIAZID 71 45 89 115
MEGESTROL ACETATE 71 52 R 89 136
FENTANYL 70 40 S2 93 104
JANTOVEN 69 69 94 260
FLUTICASONE PROPIONATE 68 35 95 43
NAPROXEN 68 50 95 72
METOCLOPRAMIDE HCL 68 20 95 119
GLIMEPIRIDE 67 50 98 37
CEPHALEXIN 66 60 99 77
MIRTAZAPINE 65 65 100 56
LISINOPRIL-HYDROCHLOROTHIAZIDE 64 35 101 23
TRAZODONE HCL 63 18 102 26
FAMOTIDINE 63 62 102 62
BENZTROPINE MESYLATE 62 28 R 104 175
DILTIAZEM 24HR CD 62 45 104 126
ISOSORBIDE DINITRATE 62 54 104 273
AGGRENOX 62 38 104 153
LEVETIRACETAM 62 28 104 170
GLIPIZIDE ER 60 33 109 88
LEXAPRO 60 47 109 201
GLIPIZIDE 60 51 109 52
TRIAMCINOLONE ACETONIDE 60 52 109 150
SPIRONOLACTONE 58 36 113 71
LIPITOR 57 52 114 127
NOVOLIN N 56 30 115 271
VENLAFAXINE HCL ER 56 28 115 121
DIVALPROEX SODIUM ER 55 45 117 146
LOVASTATIN 54 42 118 46
MONTELUKAST SODIUM 53 24 119 172
SYMBICORT 53 37 119 137
SPIRIVA 52 37 121 73
NITROSTAT 52 42 121 204
NIFEDICAL XL 51 29 123 259
QUETIAPINE FUMARATE 51 28 123 69
HYDRALAZINE HCL 50 11 125 130
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 28, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.